Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$224.99 - $256.14 $692,519 - $788,398
3,078 New
3,078 $738,000
Q2 2021

Aug 02, 2021

SELL
$225.08 - $271.69 $1.49 Million - $1.79 Million
-6,602 Closed
0 $0
Q1 2021

Apr 23, 2021

SELL
$212.38 - $245.9 $123,392 - $142,867
-581 Reduced 8.09%
6,602 $1.49 Million
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $39,525 - $45,655
-186 Reduced 2.52%
7,183 $1.6 Million
Q3 2020

Oct 21, 2020

SELL
$177.16 - $215.33 $51,199 - $62,230
-289 Reduced 3.77%
7,369 $1.59 Million
Q2 2020

Aug 11, 2020

BUY
$128.7 - $176.83 $27,155 - $37,311
211 Added 2.83%
7,658 $1.36 Million
Q1 2020

May 04, 2020

SELL
$121.39 - $169.05 $6,433 - $8,959
-53 Reduced 0.71%
7,447 $1.03 Million
Q4 2019

Feb 07, 2020

BUY
$133.47 - $153.48 $68,870 - $79,195
516 Added 7.39%
7,500 $1.15 Million
Q3 2019

Nov 01, 2019

BUY
$135.4 - $146.47 $5,686 - $6,151
42 Added 0.61%
6,984 $1.01 Million
Q2 2019

Aug 06, 2019

SELL
$124.88 - $143.73 $58,443 - $67,265
-468 Reduced 6.32%
6,942 $992,000
Q1 2019

Apr 25, 2019

BUY
$97.62 - $132.29 $6,931 - $9,392
71 Added 0.97%
7,410 $979,000
Q4 2018

Jan 24, 2019

BUY
$94.85 - $109.54 $6,260 - $7,229
66 Added 0.91%
7,339 $757,000
Q3 2018

Nov 06, 2018

SELL
$98.13 - $108.9 $10,401 - $11,543
-106 Reduced 1.44%
7,273 $790,000
Q2 2018

Aug 02, 2018

SELL
$96.1 - $103.24 $39,977 - $42,947
-416 Reduced 5.34%
7,379 $728,000
Q1 2018

Apr 30, 2018

BUY
$92.16 - $103.8 $37,785 - $42,558
410 Added 5.55%
7,795 $763,000
Q4 2017

Feb 05, 2018

BUY
$85.26 - $94.62 $67,611 - $75,033
793 Added 12.03%
7,385 $685,000
Q3 2017

Nov 01, 2017

BUY
$79.29 - $88.45 $522,679 - $583,062
6,592
6,592 $566,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $151B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bank Ozk Portfolio

Follow Bank Ozk and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Ozk, based on Form 13F filings with the SEC.

News

Stay updated on Bank Ozk with notifications on news.